Using imaging technology to measure bowel damage in Crohn's disease.
Automated Measurement of Bowel Damage Using Enterography Imaging to Predict Clinical Outcomes in Crohn’s Disease.
This study is looking at new ways to use special imaging techniques to better understand and measure bowel damage in people with Crohn's disease, so that doctors can offer more personalized treatment options based on each person's needs.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-10617199 on NIH RePORTER |
What this research studies
This research focuses on improving the management of Crohn's disease by developing automated methods to measure bowel damage through enterography imaging. It aims to enhance the accuracy of predicting clinical outcomes for patients by utilizing computational image analysis techniques. By objectively quantifying structural bowel damage, the research seeks to provide more personalized treatment options for individuals with Crohn's disease. The study will evaluate the effectiveness of these imaging methods in a clinical setting to better inform treatment decisions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Crohn's disease who are undergoing enterography imaging as part of their routine care.
Not a fit: Patients who do not have Crohn's disease or those who are not undergoing enterography imaging may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate predictions of treatment outcomes for patients with Crohn's disease, ultimately improving their care.
How similar studies have performed: Previous research has shown promise in using imaging techniques to assess bowel damage, indicating that this approach may lead to significant advancements in Crohn's disease management.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Stidham, Ryan William — University of Michigan at Ann Arbor
- Study coordinator: Stidham, Ryan William
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.